Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Astaxanthin as a Peroxisome Proliferator-Activated Receptor (PPAR) Modulator: Its Therapeutic Implications
Authors
Keywords
-
Journal
Marine Drugs
Volume 17, Issue 4, Pages 242
Publisher
MDPI AG
Online
2019-04-24
DOI
10.3390/md17040242
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acidic cultivation of Haematococcus pluvialis for improved astaxanthin production in the presence of a lethal fungus
- (2019) Sung-Won Hwang et al. BIORESOURCE TECHNOLOGY
- Differences between Motile and Nonmotile Cells of Haematococcus pluvialis in the Production of Astaxanthin at Different Light Intensities
- (2019) Feng Li et al. Marine Drugs
- Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications
- (2019) Agha Zeeshan Mirza et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Commercial Fucoidans from Fucus vesiculosus Can Be Grouped into Antiadipogenic and Adipogenic Agents
- (2018) Ruth Oliveira et al. Marine Drugs
- Protective Effect of Meretrix meretrix Oligopeptides on High-Fat-Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
- (2018) Fangfang Huang et al. Marine Drugs
- A Sterol from Soft Coral Induces Apoptosis and Autophagy in MCF-7 Breast Cancer Cells
- (2018) Jing-Ru Weng et al. Marine Drugs
- The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development
- (2018) Fan Hong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Astaxanthin exerts anti-inflammatory and antioxidant effects in macrophages in NRF2-dependent and independent manners
- (2018) Callie Farruggia et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- On the Neuroprotective Role of Astaxanthin: New Perspectives?
- (2018) Christian Galasso et al. Marine Drugs
- Anti-Obesity Effects of Collagen Peptide Derived from Skate (Raja kenojei) Skin Through Regulation of Lipid Metabolism
- (2018) Minji Woo et al. Marine Drugs
- Supercritical Carbon Dioxide Extraction of Astaxanthin, Lutein, and Fatty Acids from Haematococcus pluvialis Microalgae
- (2018) Giuseppe Sanzo et al. Marine Drugs
- Astaxanthin: A mechanistic review on its biological activities and health benefits
- (2018) Sajad Fakhri et al. PHARMACOLOGICAL RESEARCH
- Astaxanthin Inhibits Mitochondrial Dysfunction and Interleukin-8 Expression in Helicobacter pylori-Infected Gastric Epithelial Cells
- (2018) Suhn Kim et al. Nutrients
- Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
- (2018) Yibo Bai et al. Marine Drugs
- Fishing for Targets of Alien Metabolites: A Novel Peroxisome Proliferator-Activated Receptor (PPAR) Agonist from a Marine Pest
- (2018) Rosa Vitale et al. Marine Drugs
- Extraction of Astaxanthin and Lutein from Microalga Haematococcus pluvialis in the Red Phase Using CO2 Supercritical Fluid Extraction Technology with Ethanol as Co-Solvent
- (2018) Antonio Molino et al. Marine Drugs
- Astaxanthin protects lipopolysaccharide-induced inflammatory response in Channa argus through inhibiting NF-κB and MAPKs signaling pathways
- (2018) Mu-Yang Li et al. FISH & SHELLFISH IMMUNOLOGY
- Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
- (2017) Chek Kun Tan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Liver X receptors link lipid metabolism and inflammation
- (2017) Ira G. Schulman FEBS LETTERS
- Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E
- (2017) Masuko Kobori et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Two Isomeric C16 Oxo-Fatty Acids from the Diatom Chaetoceros karianus Show Dual Agonist Activity towards Human Peroxisome Proliferator-Activated Receptors (PPARs) α/γ
- (2017) Angel Moldes-Anaya et al. Marine Drugs
- The In Vitro and In Vivo Anti-Inflammatory Effects of a Phthalimide PPAR-γ Agonist
- (2017) Mingzhi Su et al. Marine Drugs
- A Combination of Flaxseed Oil and Astaxanthin Improves Hepatic Lipid Accumulation and Reduces Oxidative Stress in High Fat-Diet Fed Rats
- (2017) Jiqu Xu et al. Nutrients
- Astaxanthin acts via LRP-1 to inhibit inflammation and reverse lipopolysaccharide-induced M1/M2 polarization of microglial cells
- (2017) Xiaojun Wen et al. Oncotarget
- Cell Surface CD36 Protein in Monocyte/Macrophage Contributes to Phagocytosis during the Resolution Phase of Ischemic Stroke in Mice
- (2016) Moon-Sook Woo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt
- (2016) Yaoyao Jia et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Potential Anti-Atherosclerotic Properties of Astaxanthin
- (2016) Yoshimi Kishimoto et al. Marine Drugs
- Astaxanthin-Producing Green Microalga Haematococcus pluvialis: From Single Cell to High Value Commercial Products
- (2016) Md. Mahfuzur R. Shah et al. Frontiers in Plant Science
- Multiple Mechanisms of Anti-Cancer Effects Exerted by Astaxanthin
- (2015) Li Zhang et al. Marine Drugs
- Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases
- (2015) Haijian Wu et al. Marine Drugs
- Recent breakthroughs in the biology of astaxanthin accumulation by microalgal cell
- (2015) Alexei E. Solovchenko PHOTOSYNTHESIS RESEARCH
- Role of Peroxisome Proliferator-Activated Receptorγin Ocular Diseases
- (2015) Su Zhang et al. Journal of Ophthalmology
- Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications—A Review
- (2014) Ranga Ambati et al. Marine Drugs
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Ubiquitous transcription factor YY1 promotes zebrafish liver steatosis and lipotoxicity by inhibiting CHOP-10 expression
- (2013) Guor Mour Her et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-κB-mediated inflammation in high fructose and high fat diet-fed mice
- (2013) Saravanan Bhuvaneswari et al. CELL STRESS & CHAPERONES
- Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor γ modulator in adipocytes and macrophages
- (2012) Makoto Inoue et al. BIOCHEMICAL PHARMACOLOGY
- Astaxanthin Treatment Reduced Oxidative Induced Pro-Inflammatory Cytokines Secretion in U937: SHP-1 as a Novel Biological Target
- (2012) Lorenza Speranza et al. Marine Drugs
- Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
- (2012) Yu-Chang Chen et al. MOLECULAR NEUROBIOLOGY
- The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes
- (2012) Yaoyao Jia et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARγ) in K562 cancer cells
- (2011) Xia Zhang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
- (2011) C. Piccinni et al. DIABETES CARE
- A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells
- (2010) Nurulain T. Zaveri et al. CANCER BIOLOGY & THERAPY
- Astaxanthin improves the proliferative capacity as well as the osteogenic and adipogenic differentiation potential in neural stem cells
- (2010) Jeong Hwan Kim et al. FOOD AND CHEMICAL TOXICOLOGY
- Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor- / Antagonist GSK3787
- (2010) P. S. Palkar et al. MOLECULAR PHARMACOLOGY
- CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD
- (2009) D. M. Okamura et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- PPARs and the Cardiovascular System
- (2008) Milton Hamblin et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
- (2008) Jeffrey M. Peters et al. CLINICAL SCIENCE
- Rosiglitazone, a PPAR gamma agonist: Potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers
- (2008) Ronald A. Lubet et al. INTERNATIONAL JOURNAL OF CANCER
- Thematic Review Series: Skin Lipids.Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology
- (2008) Matthias Schmuth et al. JOURNAL OF LIPID RESEARCH
- The PPAR trio: Regulators of myocardial energy metabolism in health and disease
- (2008) Jose A. Madrazo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
- (2008) D. Panigrahy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now